Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-11-29
1997-01-14
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548496, 548455, C07D20912, C07D40312, C07D40712, A61K 3140
Patent
active
055940226
ABSTRACT:
The invention concerns tachykinin antagonists. The compounds are nonpeptides which have utility in treating disorders mediated by tachykinins. Such disorders are respiratory, inflammatory, gastrointestinal, ophthalmic, allergies, pain, vascular, diseases of the central nervous system, and migraine. Methods of preparing compounds and novel intermediates are also included.
The compounds are expected to be especially useful in asthma and rheumatoid arthritis.
REFERENCES:
patent: 4000297 (1976-12-01), Rovati et al.
patent: 5138061 (1992-08-01), Belleau et al.
D. Rehbinder, et al., Ann Chem, 1965, 681:182-7.
H. Nesvadba, Monaish, 1962, 93:386-96.
Hanson, et al., J. Biol. Chem, 1949, 179:815-817.
Physiological Reviews, 67(4):1117-1142 (1987), S. Nakanishi, "Substance P Precursor and Kininogen . . . ".
Neurochem. Int., 18(2):149-165 (1991), S. Guard et al. "Tachykinin Receptor Types: Classification and . . . ".
Annu. Rev. Neurosci., 14:123-136 (1991), S. Nakanishi, "Mammalian Tachykinin Receptors".
Pharmacological Reviews, 35(2):85-141 (1983), B. Pernow, "Substance P".
Current Opinion in Therapeutic Patents, 1:197 (1991), B. E. Tomczuk et al.
Science, 251:435-437 (1991), R. M. Snider et al., "A Potent Nonpeptide Antagonist of the Substance P . . . ".
Proc. Natl. Acad. Sci.,, 88:10208-10212 (1991), C. Garret et al., "Pharmacological properties of a potent . . . ".
Brit. J. Pharmacol., 105:78 (1992), N. Watson et al., "Demonstration of Facilitatory Role of . . . ".
Neuropeptides, 22:24 (1992), T. Fujii et al., "Effect of Novel Substance P Antagonist, FK888, on Airway . . . ".
Tomczuk, B. E. et al. Current Opinions in Therapeutic Patents 1991; 1:197.
Horwell David C.
Howson William
Pritchard Martyn C.
Rees David C.
Roberts Edward
Anderson Elizabeth M.
Springer David B.
Warner-Lambert & Company
LandOfFree
Tachykinin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tachykinin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tachykinin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1388598